Registration is open! You have another 69 days to submit your application.

Registration is open! You have another 69 days to submit your application.

APPLY

ZetaBio

Health Sciences and Wellness

ZetaBio is a biotechnology startup developing next-generation human-relevant 3D cancer models for drug screening, disease modelling and personalised medicine applications. The company focuses on advanced organoid and organ-on-a-chip systems that more accurately reproduce human tumour biology compared to conventional 2D cell cultures and animal models.

ZetaBio aims to improve the predictability of preclinical oncology research, supporting the development of safer and more effective cancer therapies, while reducing late-stage clinical failure. The platform integrates experimental 3D cancer systems with data-driven analysis and AI-supported approaches for therapeutic evaluation and patient-response prediction.

Initially focused on breast cancer, ZetaBio is designed as a scalable platform adaptable to multiple solid tumour types, including brain, prostate and lung cancers.